$115.56-3.61 (-3.03%)
Axcelis Technologies, Inc.
Axcelis Technologies, Inc. in the Technology sector is trading at $115.56 with a market capitalization of $3.4B. Wall Street consensus targets $161.00 (3 analysts), implying a +39.3% move over the next 12 months. The stock is currently 40% below its 52-week high of $193.78, remaining 1.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $215.18M↑ | $198.96M↓ | $238.33M↑ | $213.61M↑ | $194.54M |
| Gross Profit | $91.19M↑ | $80.58M↓ | $111.93M↑ | $88.81M↑ | $87.34M |
| Operating Income | $20.28M↑ | $7.95M↓ | $36.17M↑ | $25.02M↓ | $28.96M |
| Net Income | $23.29M↑ | $9.21M↓ | $34.30M↑ | $25.99M↓ | $31.38M |
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high c...

Axcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.

The participating companies are Air Products, Axcelis Technologies, Corning and Pacifico Energy

Why Axcelis Technologies Is Back On Investor Radars Axcelis Technologies (ACLS) recently announced plans to join upcoming investor conferences, including the Citi 2026 Global TMT Conference and the B. Riley Securities Consumer & TMT Conference, which has put fresh attention on the stock. The recent conference announcements come after a mixed price pattern for Axcelis Technologies, with the share price up 28.62% year to date but down 31.57% over 90 days. The 1-year total shareholder return of...

Axcelis Technologies has delivered a strong 5 year share price gain, yet the stock now screens as expensive on several valuation checks and carries a low overall value score. For investors, the recent pullback raises the question of whether this is a healthy reset or a sign that earlier enthusiasm pushed the valuation too far. Axcelis Technologies has returned about 127% over 5 years, which points to a stock that has already rewarded patient holders. The company’s ability to convert its...

Kulicke and Soffa's Q3 beat, AI-led demand, advanced packaging growth and improving memory trends point to continued momentum into fiscal 2027.